title: Restoring the salivary cortisol awakening response through nasal continuous positive airway pressure therapy in obstructive sleep apnea.
abstract: Partial and largely conflicting data are currently available on the interplay between obstructive sleep apnea (OSA) and hypothalamus-pituitary-adrenal axis (HPA) activity in adult obese men. This study was performed to evaluate the daily trajectories of salivary cortisol, specifically with respect to the salivary cortisol awakening response (CAR), a common method used to assess HPA axis activity. The main findings of this study were that adult male obese subjects who were newly diagnosed with severe OSA showed the following: (1) a flattening of the CAR; (2) levels of cortisol at awakening that were lower than those of the controls; and (3) maintenance of the physiological circadian activity of the HPA axis, with the highest hormone concentrations produced in the morning and the lowest in the evening. This study was also designed to investigate the effects of 3 and 6 mos of treatment with continuous airways positive pressure (CPAP). CPAP use resulted in a significant recovery of the sleep patterns disrupted by OSA; moreover, mild neuropsychological signs of depression and anxiety in severe OSA patients were concomitantly progressively improved by CPAP treatment. Furthermore, this study reports that 3 and 6 mos of CPAP therapy restored the presence of CAR and was able to significantly reduce the difference in the morning cortisol levels between the OSA and control groups. In conclusion, we report here that compared with obese nonapneic matched controls, OSA patients present a dysregulation of HPA axis activity, as shown by the flattening of the diurnal pattern of cortisol production in response to repeated challenge due to hypoxia and sleep fragmentation. This dysregulation was especially detectable in the first hour after awakening and restored after 3 and 6 mos of treatment with CPAP.
authors.affiliation: Department of Pharmacology, School of Medicine, University of Medicine and Pharmacy Grigore T. Popa, Iasi, Romania.
authors.forename: Cristina Mihaela
authors.initials: CM
authors.lastname: Ghiciuc
authors.forename: Lucia Corina
authors.initials: LC
authors.lastname: Dima Cozma
authors.forename: Raluca Mihaela
authors.initials: RM
authors.lastname: Bercea
authors.forename: Catalina Elena
authors.initials: CE
authors.lastname: Lupusoru
authors.forename: Traian
authors.initials: T
authors.lastname: Mihaescu
authors.forename: Andreea
authors.initials: A
authors.lastname: Szalontay
authors.forename: Angela
authors.initials: A
authors.lastname: Gianfreda
authors.forename: Francesca Romana
authors.initials: FR
authors.lastname: Patacchioli
mesh_terms: D000328:Adult; D000704:Analysis of Variance; D002940:Circadian Rhythm; D045422:Continuous Positive Airway Pressure; D006801:Humans; D006854:Hydrocortisone / Q000378:metabolism*; D007030:Hypothalamo-Hypophyseal System / Q000378:metabolism* / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D009765:Obesity / Q000150:complications; D010913:Pituitary-Adrenal System / Q000378:metabolism* / Q000503:physiopathology; D011446:Prospective Studies; D020127:Recovery of Function; D012463:Saliva / Q000378:metabolism*; D012890:Sleep; D020181:Sleep Apnea, Obstructive / Q000175:diagnosis / Q000209:etiology / Q000378:metabolism / Q000503:physiopathology / Q000628:therapy*; D013997:Time Factors; D016896:Treatment Outcome; D014851:Wakefulness
chemical_list: D006854:Hydrocortisone